David Blecken
Oct 17, 2008

Boehringer Ingelheim selects Vizeum in China

SHANGHAI - German pharmaceutical giant Boehringer Ingelheim has picked Vizeum China to handle media duties for its Mucosolvan cough remedy, following a review that also included incumbent MediaCom and Hakuhodo.

Boehringer Ingelheim selects Vizeum in China
Vizeum will reportedly develop a range of materials and initiatives for the brand, including point-of-sale promotions, advertorials, healthcare booklets, trade communications and community events. The Aegis Group agency restructured as a full-service operation earlier this year.

As the world’s leading expectorant, Mucosolvan positions itself as a remedy that enables mothers to care for their families.

Source:
Campaign China

Related Articles

Just Published

23 hours ago

Former Dentsu China CEO Deric Wong joins EternityX

EXCLUSIVE: The media agency veteran who left Dentsu China to start a consulting firm will oversee the global expansion at the Hong Kong-headquartered martech company.

23 hours ago

Top 10 travel brands in Southeast Asia

Vietnam Airlines soars above the competition, claiming the title of Southeast Asia’s top travel brand in 2024. Explore Campaign’s exclusive insights from its research with Milieu Insight.

1 day ago

Apple’s latest campaign celebrates innovation in ...

Known as ‘circles', the student-led teams push boundaries in fields including hybrid rocket engineering, stop-motion animation, game development and sports analytics.

1 day ago

Ahead of Trump's second-term, Meta to scrap fact ...

Traditional fact-checking will make way for X-inspired "community notes." This drastic overhaul signals a major shift in content moderation as the tech giant appears to appease the incoming Trump administration.